2019-03-13 | The Threat of the Gray Market is Real

No country is immune from the ravages of drug addiction, abuse and overdose. Last month, news broke of the rising number of deaths in Northern Ireland and the entire UK in general due to counterfeit Xanax which is indicative of this global epidemic. It doesn’t matter if a drug is legalized, prescription-only or not even for sale in a country. If there is a demand for it, it will be available by some channel. No software company, Systech included, is going to stop counterfeiters from...

Read more »
2019-02-18 | What’s All the Buzz About Counterfeit Wine and Spirits?

In partnership with SafeProof.

Bootlegging alcohol didn’t get left behind in the Prohibition Era. In fact, according to a 2014 report by the World Health Organization, unregulated alcohol makes up 25% of all consumption worldwide. But what are the implications of fake alcohol? Why should everyone from consumers to manufacturers to government entities care? Let’s take a look at the facts.

Read more »
2017-09-08 | Diversion in the Pharmaceuticals Market

The opioid crisis in the United States has been described as an epidemic requiring urgent action on the part of government, law enforcement, health advocates and other stakeholders. A substantial portion of overdose deaths result from opioids produced by reputable manufacturers for legitimate medical purposes that have been redirected to illegitimate use. This transfer of a legal substance to illegitimate or illicit use is known as diversion, and represents a major challenge in the...

Read more »
2017-08-25 | Our View: Counterfeiting the Gray Market

Advisory firm KPMG recently conducted a detailed survey of executives from companies within a technology supply chain to find out how gray market trading was impacting them.  The report and its findings are applicable in many commercial supply chains; and so, we recommend you download it from KPMG.

Read more »